Autophagy-mediated Insulin Receptor Down-regulation Contributes to Endoplasmic Reticulum Stress-induced Insulin Resistance
Overview
Pharmacology
Authors
Affiliations
Endoplasmic reticulum (ER) stress is associated with obesity-induced insulin resistance, yet the underlying mechanisms remain to be fully elucidated. Here we show that ER stress-induced insulin receptor (IR) down-regulation may play a critical role in obesity-induced insulin resistance. The expression levels of IR are negatively associated with the ER stress marker C/EBP homologous protein (CHOP) in insulin target tissues of db/db mice and mice fed a high-fat diet. Significant IR down-regulation was also observed in fat tissue of obese human subjects and in 3T3-L1 adipocytes treated with ER stress inducers. ER stress had little effect on IR tyrosine phosphorylation per se but greatly reduced IR downstream signaling. The ER stress-induced reduction in IR cellular levels was greatly alleviated by the autophagy inhibitor 3-methyladenine but not by the proteasome inhibitor N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132). Inhibition of autophagy prevented IR degradation but did not rescue IR downstream signaling, consistent with an adaptive role of autophagy in response to ER stress-induced insulin resistance. Finally, chemical chaperone treatment protects cells from ER stress-induced IR degradation in vitro and obesity-induced down-regulation of IR and insulin action in vivo. Our results uncover a new mechanism underlying obesity-induced insulin resistance and shed light on potential targets for the prevention and treatment of obesity-induced insulin resistance and type 2 diabetes.
Wang J, Jurado-Aguilar J, Barroso E, Rodriguez-Calvo R, Camins A, Wahli W Cell Commun Signal. 2024; 22(1):595.
PMID: 39696437 PMC: 11656877. DOI: 10.1186/s12964-024-01972-5.
Role of Autophagy in Type 2 Diabetes Mellitus: The Metabolic Clash.
Alanazi Y, Al-Kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Bahaa M J Cell Mol Med. 2024; 28(23):e70240.
PMID: 39656379 PMC: 11629865. DOI: 10.1111/jcmm.70240.
Jiang Y, Guo J, Wu Y, Zheng P, Wang S, Yang M Ther Adv Endocrinol Metab. 2024; 15:20420188241282707.
PMID: 39381518 PMC: 11459521. DOI: 10.1177/20420188241282707.
Bidooki S, Barranquero C, Sanchez-Marco J, Martinez-Beamonte R, Rodriguez-Yoldi M, Navarro M Int J Mol Sci. 2024; 25(13).
PMID: 39000233 PMC: 11241358. DOI: 10.3390/ijms25137128.
Shen J, Wang X, Wang M, Zhang H Front Physiol. 2024; 15:1337442.
PMID: 38818523 PMC: 11137309. DOI: 10.3389/fphys.2024.1337442.